Increased expression of c-Kit or its ligand Steel Factor is not a common feature of adult acute myeloid leukaemia

Leukemia

Volumn 10, Issue 2, 1996, Pages 288-296

  Cole, S R ^a   Avlett, G W ^a   Casey, G ^a   Harvey, N L ^a   Cambareri, A C ^a   Ashman, L K ^a  

^a INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

Author keywords

AML; c Kit; SLF

Indexed keywords

CD34 ANTIGEN; CELL SURFACE RECEPTOR; MESSENGER RNA; PROTEIN P145; PROTEIN TYROSINE KINASE; STEEL FACTOR; STEM CELL FACTOR; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BONE MARROW CELL; CELL MATURATION; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; INTERNALIZATION; ONCOGENE C KIT; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN METABOLISM; PROTO ONCOGENE; SOUTHERN BLOTTING; STEM CELL;

EID: 0029886011     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Galli SJ, Zsebo KM, Geissler EN. The kit ligand, stem cell factor Advances Immunol 1994; 55: 1-96.
2. Ashman LK et al. Expression of the YB5.B8 antigen (c-kit proto-oncogene product) in normal human bone marrow. Blood 1991, 78: 30-37.
3. Papayannopoulou T, Brice M, Broudy VC, Zsebo KM. Isolation of c-kit receptor-expressing cells from bone marrow, peripheral blood and fetal liver: functional properties and composite antigenic profile. Blood 1991; 78: 1403-1412.
4. Briddell RA et al. Further phenotypic characterization and isolation of human hematopoietic progenitor cells using a monoclonal antibody to the c-kit receptor. Blood 1992; 79: 3159-3167
5. Simmons PJ et al. c-kit is expressed by primitive human hematopoietic cells that give rise to colony-forming cells in stroma-dependent or cytokine-supplemented culture. Exp Hematol 1994; 22: 157-165.
6. Gadd SJ, Ashman LK. A murine monoclonal antibody specific for a cell-surface antigen expressed by a sub-group of human myeloid leukemias. Leukemia Res 1985; 9: 1329-1336.
7. Ashman LK et al. Expression of a 150 kDa cell surface antigen identified by monoclonal antibody YB5.B8 is associated with poor prognosis in acute non-lymphoblastic leukaemia. Leukemia Res 1988; 12: 923-928.
8. Reuss-Borst MA, Buhring H-J, Schmidt H, Muller CA, AML. Immunophenotypic heterogeneity and prognostic significance of c-kit expression. Leukemia 1994; 8: 258-263.
9. Alexander WS, Lyman SD, Wagner EF. Expression of functional c-kit receptors rescues the genetic defect of W mutant mast cells. EMBO J 1991; 10: 3683-3691
10. Velu TJ et al. Epidermal growth factor-dependent transformation by a human EGF receptor proto-oncogene Science 1987; 238 1408-1410.
11. INK 2 causes transformation and tumorigenesis in NIH3T3 cells. Proc Natl Acad Sci USA 1987; 84 7159-7163
12. Besmer P et al A new acute transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene family. Nature 1986; 320: 415-421.
13. Downward I et al. Close similarity of epidermal growth factor receptor and v-erbB oncogene protein sequences. Nature 1984; 307: 521-527.
14. d mutant. Cell 1991; 64: 1025-1035.
15. Levesque JP et al. Cytokines increase human haemopoietic cell adhesiveness by activation of VLA-4 and VLA-5 integrins. J Exp Med 1995; 181: 1805-1815.
16. Hibi K et al. Coexpression of the stem cell factor and the c-kit genes in small cell lung cancer. Oncogene 1991; 6: 2291-2296.
17. Matsuda R et al. Expression of the c-kit protein in human solid tumors and in corresponding fetal and adult normal tissues. Am J Pathol 1993; 142: 339-346.
18. Russell NH. Autocrine growth factors and leukaemic haemopoiesis: Blood Rev 1992; 6: 149-156.
19. Broxmeyer HE et al. Effect of murine mast cell growth factor (c-kit proto-oncogene ligand) on colony formation by human marrow hematopoietic progenitor cells. Blood 1991; 77: 2142-2149.
20. McNiece IK, Langley KE, Zsebo KM. Recombinant human stem cell factor synergizes with GM-CSF, G-CSF, IL-3 and epo to stimulate human progenitor cells of the myeloid and erythroid lineages. Exp Hematol 1991; 19: 226-231.
21. Metcalf D, Nicola NA. Direct proliferative actions of stem cell factor on murine bone marrow cells in vitro: effects of combination with colony-stimulating factors. Proc Natl Acad Sci USA 1991; 88: 6239-6243.
22. Butterfield JH, Weiler D, Dewald G, Gleich GJ. Establishment of an immature mast cell line from a patient with mast cell leukemia. Leukemia Res 1988; 12: 345-355.
23. Tohda S et al. Relationship between c-KIT expression and proliferation in acute myeloblastic leukemia cell lines. J Cell Physiol 1993; 154: 410-418.
24. Ashman LK, Aylett GW, Cambareri AC, Cole SR. Different epitopes of the CD31 antigen identified by monoclonal antibodies: cell type-specific patterns of expression. Tissue Antigens 1991; 38: 199-207.
25. Ashman LK et al. Epitope mapping and functional studies with three monoclonal antibodies to the c-KIT receptor tyrosine kinase, YB5.B8, 17F11, and SR-1. J Cell Physiol 1994; 158: 545-554.
26. Lerner NB et al. Monoclonal antibody YB5.B8 identifies the human c-kit protein product. Blood 1991; 77: 1876-1883.
27. O'Connor CG, Ashman LK. Application of the nitrocellulose transfer technique and alkaline phosphatase conjugated anti-immunoglobulin for determination of the specificity of monoclonal antibodies to protein mixtures. J Immunol Methods 1982; 54: 267-271.
28. Andrews RG, Singer JW, Bernstein ID. Monoclonal antibody 12-8 recognizes a 115-Kd molecule present on both unipotent and multipotent hematopoietic colony-forming cells and their precursors. Blood 1986; 67: 842-845.
29. Chomczynski P, Sacchi N. Single step method of RNA isolation by guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
30. Goodall GJ, Filipowicz W. The AU-rich sequences present in the introns of plant nuclear pre-mRNAs are required for splicing. Cell 1989; 58: 473-483.
31. Kinloch RA, Roller RJ, Wassarman PM. Quantitative analysis of specific messenger RNAs by ribonuclease protection. Meth Enzymol 1993; 225 294-303.
32. Caruana G, Ashman LK, Fujita J, Gonda TJ. Responses of the murine cell line FDC-P1 to soluble and membrane-bound forms of steel factor (SLF) Exp Haematol 1993; 21: 761-768.
33. Sambrook I, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory: Cold Spring Harbor, NY, 1989.
34. Willman CL et al. Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia. Science 1993; 259: 968-971.
35. + cells. Blood 1994; 84: 2930-2939.
36. Zar JH. Biostatistical analysis, 2nd edn. Prentice Hall: New Jersey, 1984.
37. Yarden Y et al. Human proto-oncogene c-kit: a new cell surface receptor kinase for an unidentified ligand. EMBO J 1987; 6: 3341-3351.
38. Sherr CJ et al. The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1. Cell 1985; 41: 665-676.
39. Slamon DJ et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 1989; 244: 707-712.
40. Broudy VC et al. Blasts from patients with acute myelogenous leukemia express functional receptors for stem cell factor. Blood 1992; 80: 60-67.
41. Smith FO et al. Cell surface expression of c-kit receptors by childhood acute myeloid leukemia blasts is not of prognostic value: a report from the Childrens Cancer Group. Blood 1994; 84: 847-852.
42. Furitsu T et al. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. J Clin Invest 1993; 92: 1736-1744.
43. Natali PG et al. Expression of c-kit receptor in normal and transformed human non-lymphoid tissues. Cancer Res 1992; 52: 6139-6143.
44. Hines SJ, Organ C, Kornstein MJ, Krystal GW. Co-expression of c-kit and stem cell factor genes in breast carcinomas. Cell Growth Differ 1995; 6: 769-779.
45. Ryan JJ et al. Role for the stem cell factor/KIT complex in Schwann cell neoplasia and mast cell proliferation associated with neurofibromatosis. J Neuroscience Res 1994; 37: 415-432.
46. Turner AM et al. Nonhematopoietic tumor cell lines express stem cell factor and display c-kit receptors. Blood 1992; 80: 374-381.
47. Ymer S et al. Constitutive synthesis of interleukin-3 by leukaemia cell line WEHI-3B is due to retroviral insertion near the gene. Nature 1985; 317: 255-258.
48. Pietsch T et al. Effects of human stem cell factor (c-kit ligand) on proliferation of myeloid leukemia cells: heterogeneity in response and synergy with other hematopoietic growth factors. Blood 1992; 80: 1199-1206.
49. Langley KE et al. Soluble stem cell factor in human serum. Blood 1993; 81: 656-660.
50. Tsujimura T et al. Ligand-independent activation of c-kit receptor tyrosine kinase in a murine mastocytoma cell line P-815 generated by a point mutation. Blood 1994; 83: 2619-2626.
51. Nocka K et al. Expression of c-kit gene products in known cellular targets of W mutations in normal and W mutant mice - evidence for an impaired c-kit kinase in mutant mice. Genes Dev 1989; 3. 816-826.
52. Irani A-M et al. Recombinant Human Stem Cell Factor stimulates differentiation of mast cells from dispersed human fetal liver cells. Blood 1992; 80: 3009-3021.